[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100522331":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":33,"responsibleParty":50,"collaborators":10,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":10,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":60,"maxAge":61,"enrollmentInfo":62,"targetDuration":10,"studyType":65,"phases":10,"briefSummary":66,"conditions":67,"keywords":69,"overallStatus":36,"whyStopped":10,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Third Affiliated Hospital, Sun Yat-Sen University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"open-source APS",null,"open-source APS consisted of an insulin pump, a CGM system, and a heuristic algorithm on an Android smartphone.",[13],"Device: open-source APS;",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","open-source APS;","a continuous glucose monitoring system, an insulin pump, and an intelligent algorithm.",[9],[21],{"name":22,"affiliation":5,"role":23},"Jinhua Yan, PHD,MD","PRINCIPAL_INVESTIGATOR",[25,29],{"name":22,"role":26,"phone":27,"phoneExt":10,"email":28},"CONTACT","+8613929589959","yanjh79@163.com",{"name":30,"role":26,"phone":31,"phoneExt":10,"email":32},"Wen Xu, PHD,MD","02085253000","xwen@mail.sysu.edu.cn",[34],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Jinhua Yan","RECRUITING","Guangzhou","Guangdong","510630","China","CN",{"type":43,"coordinates":44},"Point",[45,46],113.25,23.11667,{"lat":46,"lon":45},[49],{"name":35,"role":26,"phone":27,"phoneExt":10,"email":28},{"type":23,"investigatorFullName":35,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Vice Professor,Principal Investigator,Department of Endocrinology and Metabolism","100522331","open-source-artificial-pancreas-system-use-among-people-with-type-1-diabetes-mellitus-in-china-100522331",false,"NCT06081231","Open-Source Artificial Pancreas System Use Among People With Type 1 Diabetes Mellitus in China","The Safety and Efficacy of Open-Source Artificial Pancreas System Among People With Type 1 Diabetes Mellitus in China","Inclusion Criteria:\n\n1. diagnosed T1DM.\n2. Currently use open-source APS for at least 3 months.\n3. Willing and able to provide informed consent (or be a parent or other legally authorized representative) and to provide the data.\n4. reside in China.\n\nExclusion Criteria:\n\nNone","ALL","3 Years","75 Years",{"count":63,"type":64},500,"ESTIMATED","OBSERVATIONAL","This real-world observational study aims to reveal the current status of the open-source artificial pancreas system (APS) use among people with T1DM in China and assess the glycemic efficacy and potential related factors of the open-source APS.",[68],"Type 1 Diabetes Mellitus",[70,71,72,73,74],"artificial pancreas system","automated insulin delivery","do-it-yourself","closed loop","open source","2024-06-20",{"date":77,"type":78},"2024-06-24","ACTUAL",{"date":80,"type":78},"2019-01-01",{"date":82,"type":64},"2026-06-01",{"name":5,"class":6},1]